Data as of:
brimindinvest.com / compare / hon-vs-emrLIVE
HON
Honeywell International Inc. · Industrials
$206.46
-6.89% this month
VERSUS
COMPARE
EMR
Emerson Electric Co. · Industrials
$149.92
-4.87% this month
Comparison scoreboard
EMR LEADS 4/5
AI Scorei
HON 42.0
EMR 52.3
1Y Returni
HON -1.78%
EMR +13.65%
Fwd P/Ei
HON 21.74
EMR 21.42
Target Up.i
HON +21.46%
EMR +10.72%
Op. Margini
HON 20.25%
EMR 26.92%
Metrics last refreshed: 9/20/2026
Quick take

HON vs EMR Stock Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

Honeywell and Emerson Electric are both major industrial automation companies — competing in process control, industrial instruments, and automation software while pursuing different portfolio strategies. Honeywell remains diversified across aerospace, building, industrial, and materials segments. Emerson has simplified toward pure-play automation with AspenTech software. Both serve similar end markets (oil & gas, chemicals, manufacturing) but with different business compositions.

HON vs EMR is the diversified industrial conglomerate with aerospace upside and automation controls across multiple sectors (Honeywell) versus the focused pure-play automation company transformed through portfolio restructuring with AspenTech industrial software (Emerson) — diversified industrial scale vs pure-play automation focus.

Live analysis · updated 9/20/2026

EMR holds the edge across 4 of 5 key metrics in this comparison. EMR leads on both 1-year return (+13.65%) and forward P/E quality (21.42x vs 21.74x for HON), a relatively favorable combination of momentum and valuation. EMR leads on both revenue growth (7.00%) and operating margin (26.92%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for HON (+21.46%) than for EMR (+10.72%).

Normalized 1Y performance
HON
EMR
Recent returns
HON
EMR
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

HON · 23 analysts
STRONG BUYHOLDSTRONG SELL
Buy (2.1/5.0)
14 Buy / 8 Hold / 1 Sell
Price target range
analyst low$203.00
analyst high$300.00
analyst mean$264.09
current price$206.46
+21.5% upside to analyst mean
EMR
Price target range
analyst mean$171.81
current price$149.92
+10.7% upside to analyst mean
Who should consider this stock?
HON may suit investors who:
  • prefer diversified industrial exposure with strong aerospace segment benefiting from commercial aviation recovery alongside automation and building technology businesses
  • value Honeywell's brand recognition and installed base across oil & gas, aerospace, chemicals, and commercial buildings
  • want industrial dividend growth with Honeywell's history of consistent payouts across industrial cycles
  • are comfortable with conglomerate discount, portfolio complexity across 4+ very different market segments, and portfolio reshaping execution risk
EMR may suit investors who:
  • prefer pure-play automation company focus after portfolio simplification — Emerson's cleaner automation + AspenTech story may unlock conglomerate discount relative to Honeywell
  • value AspenTech industrial software as a unique SaaS revenue stream within an automation company — software-led automation multiple expansion potential
  • want Emerson's simpler, cleaner industrial automation story with exposure to oil & gas, chemicals, and life sciences automation demand
  • are comfortable with transformation complexity, AspenTech minority ownership accounting, and automation cycle sensitivity to industrial capex
Performance & AI score
Performance & AI score
MetricHONEMR
AI scorei42.052.3
AI ranki#976#401
Latest closei$206.46$149.92
1M returni-6.89%-4.87%
6M returni-9.85%+15.41%
1Y returni-1.78%+13.65%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodHONEMR
1Y ago$9.82K (-1.8%)
started 2025-09-18
$11.37K (+13.7%)
started 2025-09-18
5Y ago$11.22K (+12.2%)
started 2021-09-20
$18.62K (+86.2%)
started 2021-09-20
10Y ago$27.58K (+175.8%)
started 2016-09-19
$47.1K (+371.0%)
started 2016-09-19

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricHONEMR
Market capi$68.91B$86.56B
Trailing P/Ei8.3634.03
Forward P/Ei21.7421.42
Price/Salesi3.75N/A
EV/Revenuei2.505.27
Analyst targeti$264.09$171.81
Target upsidei+21.46%+10.72%
Growth, profitability & risk
Growth, profitability & risk
MetricHONEMR
Revenue growthi4.30%7.00%
Earnings growthi263.90%23.00%
EPS growthi+263.90%+23.00%
FCF margini+6.86%+19.89%
Operating margini20.25%26.92%
Profit margini21.58%13.83%
ROIC proxyi46.58%12.80%
Return on equityi46.58%12.80%
Dividend yieldi1.29%1.43%
Payout ratioi36.14%47.98%
Dividend growth streakiNo increase yetNo increase yet
Betai0.921.24
Debt/equityi185.3767.68
Current ratioi1.210.90
Quick ratioi0.760.62
Correlation

Over the past year, HON and EMR have moved moderately in the same direction (correlation of 0.50), based on daily returns.

1Y
0.50
-1.0+1.0
5Y
0.55
-1.0+1.0
10Y
0.67
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
HON max drawdowni19.06%
EMR max drawdowni23.74%
HON max wkly dropi10.46%
EMR max wkly dropi8.22%
5Y risk snapshot
HON max drawdowni25.21%
EMR max drawdowni29.61%
HON max wkly dropi14.33%
EMR max wkly dropi15.00%
10Y risk snapshot
HON max drawdowni43.01%
EMR max drawdowni50.77%
HON max wkly dropi24.70%
EMR max wkly dropi28.66%
Performance metrics by period
Performance metrics by period
PeriodMetricHONEMR
1YGrowthi-1.78%+13.65%
CAGRi-1.78%+13.66%
Volatilityi27.03%31.86%
Sharpe ratioi-0.100.42
Sortino ratioi-0.140.60
Max drawdowni19.06%23.74%
Current drawdowni17.01%8.80%
Avg drawdowni7.64%7.99%
Ulcer Indexi9.25%9.95%
Max daily dropi6.00%6.26%
Max wkly dropi10.46%8.22%
5YGrowthi+3.49%+71.45%
CAGRi+0.69%+11.40%
Volatilityi22.70%27.76%
Sharpe ratioi-0.050.37
Sortino ratioi-0.080.53
Max drawdowni25.21%29.61%
Current drawdowni17.01%8.80%
Avg drawdowni9.68%8.46%
Ulcer Indexi11.20%10.40%
Max daily dropi7.62%8.65%
Max wkly dropi14.33%15.00%
10YGrowthi+126.50%+266.68%
CAGRi+8.52%+13.88%
Volatilityi24.04%29.28%
Sharpe ratioi0.270.44
Sortino ratioi0.390.62
Max drawdowni43.01%50.77%
Current drawdowni17.01%8.80%
Avg drawdowni8.30%9.23%
Ulcer Indexi10.72%11.96%
Max daily dropi12.09%18.96%
Max wkly dropi24.70%28.66%
AI Prediction Signali
Members only
Next 5 trading days
HON
+2.8%BUY
EMR
+1.1%HOLD
Next 30 trading days
HON
+6.4%BUY
EMR
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryHONEMR
CompanyHoneywell International Inc.Emerson Electric Co.
SectorIndustrialsIndustrials
IndustryConglomeratesSpecialty Industrial Machinery
Core businessHoneywell is a diversified industrial conglomerate providing automation controls, aerospace equipment, performance materials, and building technologies. Key segments include Aerospace Technologies (aircraft equipment, avionics, engines), Industrial Automation (warehouse automation, process control for oil & gas and chemicals), Building Automation (HVAC, fire, security), and Energy & Sustainability Solutions. Honeywell has been selectively separating businesses — the planned separation of its Advanced Materials segment was announced in 2024.Emerson Electric has transformed from a broad industrial conglomerate into a focused automation company through portfolio restructuring. After selling climate businesses to create Copeland (HVAC compressors), acquiring AspenTech (industrial software), and divesting industrial tools, Emerson focuses on Intelligent Devices (automation valves, actuators, sensors) and Software & Control (AspenTech, DeltaV process control). Emerson serves oil & gas, chemicals, life sciences, food & beverage, and power industries globally.
Investor focusInvestors track aerospace order growth (the fastest-growing segment), industrial automation adoption, software-defined automation growth, and Honeywell's portfolio reshaping plans.Investors track automation order backlog, AspenTech software revenue growth (the SaaS component enabling multiple expansion), and overall Intelligent Devices margin improvement.
HON strengths
  • Aerospace segment growth is exceptional — aircraft production ramp and air travel recovery are driving strong aerospace equipment demand
  • Software-defined automation (Honeywell Forge) positions the company for digital industrial revenue beyond hardware
  • Process automation installed base in oil & gas, chemicals, and power generation creates long-term service and maintenance recurring revenue
EMR strengths
  • Pure-play automation focus after portfolio transformation — Emerson's simplification is expected to unlock conglomerate discount and improve management focus
  • AspenTech industrial software is a unique digital industrial asset — process simulation and optimization software is deeply embedded in petrochemical and engineering workflows
  • Process automation installed base in oil & gas and chemicals provides long-term aftermarket parts and service revenue complementing new project sales
Risks to watch — HON
  • Honeywell's portfolio complexity (4+ major segments) creates conglomerate discount — each segment has different cycles and competitors
  • Portfolio reshaping (Advanced Materials separation) may not fully realize sum-of-parts value if capital markets remain skeptical of conglomerates
  • Industrial automation faces competition from Emerson, ABB, Siemens, and Rockwell Automation in specific market segments
Risks to watch — EMR
  • Transformation complexity — selling climate businesses, integrating AspenTech, and refocusing took years and created operational uncertainty during transition
  • AspenTech integration and minority ownership structure (Emerson owns 57%) creates accounting complexity in earnings reporting
  • Honeywell, Siemens, and ABB compete directly with Emerson's automation products — no single player dominates process automation
Frequently asked questions
Honeywell's aerospace strength in the current aviation upcycle provides a clear near-term growth catalyst. Emerson's pure-play automation focus and AspenTech software multiple expansion story offers a different thesis around conglomerate discount removal. Both are quality industrial companies; Honeywell has more earnings diversification; Emerson has more focused automation thesis with software upside.
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp